Your browser doesn't support javascript.
loading
Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome.
Dillon, Laura W; Gui, Gege; Logan, Brent R; Fei, Mingwei; Ghannam, Jack; Li, Yuesheng; Licon, Abel; Alyea, Edwin P; Bashey, Asad; Devine, Steven M; Fernandez, Hugo F; Giralt, Sergio; Hamadani, Mehdi; Howard, Alan; Maziarz, Richard T; Porter, David L; Warlick, Erica D; Pasquini, Marcelo C; Scott, Bart L; Horwitz, Mitchell E; Deeg, H Joachim; Hourigan, Christopher S.
Afiliação
  • Dillon LW; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Gui G; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Logan BR; Medical College of Wisconsin, Milwaukee, WI.
  • Fei M; Medical College of Wisconsin, Milwaukee, WI.
  • Ghannam J; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Li Y; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
  • Licon A; ArcherDX, Boulder, CO.
  • Alyea EP; Dana Farber Cancer Institute, Boston, MA.
  • Bashey A; Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA.
  • Devine SM; National Marrow Donor Program and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
  • Fernandez HF; Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Giralt S; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hamadani M; West Virginia University Medicine, Morgantown, WV.
  • Howard A; National Marrow Donor Program and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
  • Maziarz RT; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Porter DL; University of Pennsylvania, Philadelphia, PA.
  • Warlick ED; University of Minnesota, Minneapolis, MN.
  • Pasquini MC; Medical College of Wisconsin, Milwaukee, WI.
  • Scott BL; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Horwitz ME; Duke University, Durham, NC.
  • Deeg HJ; Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Hourigan CS; Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
JCO Precis Oncol ; 52021.
Article em En | MEDLINE | ID: mdl-34036237
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article